Ravagalimab
Product Specifications
CAS Number
2050816-56-1
Target
TNF
Related Pathways
Apoptosis
Purity
0.995
Bioactivity
Ravagalimab (ABBV-323) is a CD40 antagonist monoclonal antibody with an EC50 of 3.7 nM. Ravagalimab is being investigated for the treatment of inflammatory diseases such as Crohn’s disease and Sjögren’s syndrome (SS) . Research focuses on evaluating its pharmacological activity, efficacy, and safety in patients with primary Sjögren’s syndrome (pSS), highlighting its role in immune modulation.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1223800-01 0.02 mg (E-Coli)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit C (nuoC)
Sign In for Pricing
View Details MBS1223800-02 0.1 mg (E-Coli)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit C (nuoC)
Sign In for Pricing
View Details MBS1223800-03 0.02 mg (Yeast)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit C (nuoC)
Sign In for Pricing
View Details MBS1223800-04 0.1 mg (Yeast)
Recombinant Coxiella burnetii NADH-quinone oxidoreductase subunit C (nuoC)
Sign In for Pricing
View Details